Work

Supplementary Figures 1-3 from Antibody-Dependent Cellular Phagocytosis by Macrophages is a Novel Mechanism of Action of Elotuzumab

Year: 2023

Type: supplementary-materials

Abstract: Supplementary Figure 1. In-vivo mouse model's schema; Supplementary Figure 2. Total BLI Flux of SCID.beige myeloma xenograft model and Kaplan-Meier survival analysis of the NSG xenograft model; Supplementary Figure 3. Elotuzumab does not affect myeloma cell proliferation and homing to the bone marrow.

DOI: 10.1158/1535-7163.22505803.v1

Authors: Ahmed T. Kurdi, Siobhan V. Glavey, Natalie A. Bezman, Amy Jhatakia, Jennifer L. Guerriero, Salomon Manier, Michele Moschetta, Yuji Mishima, Aldo Roccaro, Alexandre Detappe, Chia-Jen Liu, Antonio Sacco, Daisy Huynh, Yu-Tzu Tai, Michael D. Robbins, Jamil Azzi, Irene M. Ghobrial

Language: English

Topic: Multiple Myeloma Research and Treatments

Subfield: Hematology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: gold

OpenAlex ID: W4362623151

Cites:

Cited by:

Related to: 10